The care primer A plain-language guide to online peptide care
Chapters ↓

Care before enrollment

Telehealth peptide program: start with the care.

Understand the visit before you choose the program.

Rules as of September 26, 2026.

What are you being offered?

A telehealth visit can use video, a telephone conversation, or online messages in place of meeting in one room.

A peptide joins the building blocks of proteins into a small chain. Insulin belongs to this group.

Calling a product a peptide leaves its safety and legal status unanswered. The exact medicine matters.

An empty chair beside a small wooden desk and a denim-blue curtain in soft window light.
A quiet place to read an offer and gather your questions.

Online care can be real

For ordinary medicines that are not controlled drugs, federal law does not demand a first visit in person. Controlled drugs have special rules about misuse. State rules still apply.

According to the national group representing state medical boards, the level of care must be equal for online and in-person visits. The doctor or other health professional needs to learn about your health before deciding on treatment.

Start with the person making that decision. Then ask about the exact product and the pharmacy that sends it. Read the whole bill before agreeing to a plan.

Separate the visit from the medicine

Some peptide medicines are FDA-approved; those initials mean Food and Drug Administration. When a pharmacy mixes a medicine for an order, that is a compounded product without FDA approval.

Weight-loss products labelled for research but offered for use by people draw an FDA warning against their use. These products could cause harm, and their quality remains unknown.

See the care path Keep the questions nearby
Source notes for this page

The medical boards' national group offers advice on how care should work. Your state's rules decide what is required.